AI sparring partner for B2B sales teamsvsGenetic-risk screening platform for full-family testing

Genetic-risk screening platform for full-family testing

Seven out of ten at-risk family members never get tested. Not because they refuse, but because the outreach never reaches them. A genetic counselor identifies a hereditary cancer risk, and cascade screening stalls at the point of coordination. Letters go unsent. Calls go unreturned. Family members who would have said yes never get the chance. Lineage AI takes the coordination off the counselor's desk. Upload a patient's test results and the platform maps the family tree, identifies at-risk relatives, and handles outreach through text, email, or letter. Each message is timed and personalized, reaching family members in the format most likely to get a response. Consent, scheduling, and compliance logging follow automatically. The counselor manages one dashboard instead of fifty spreadsheets. Start with five genetic counseling practices focused on hereditary cancer, where cascade screening protocols are well-defined and reimbursement pathways already exist. Build a web dashboard that ingests test results and lets counselors map family structures by hand during the first version. HIPAA-compliant messaging handles outreach across text, email, and letter. A lightweight CRM underneath tracks who's been contacted, who responded, and who completed testing. The metric is cascade completion rate against the industry baseline of 30 percent. Anything above that in the first cohort proves the coordination was the bottleneck all along. Genetic counseling practices pay $500 to $2,000 a month based on patient volume. Health systems with in-house genetics departments license it for $25,000 to $100,000 annually. Payer partnerships come next. Insurers save money when at-risk patients get tested before they develop cancer rather than after. Hereditary cancer is the entry point. Cardiovascular genetics, pharmacogenomics, and rare disease registries expand the platform into adjacent verticals where cascade screening has the same coordination problem. Cascade rates have been stuck at 30 percent for years. The coordination is the bottleneck, and everything on the other side of fixing it is growth. *Analysis, scores, and revenue estimates are educational and based on assumptions. Results vary by execution and market conditions.

0 dimension wins